Electronic Skin Patch Market by Type (Monitoring & Diagnostic, Therapeutic), Wireless Connectivity (Connected, Non-connected), Application (Diabetes Management, Cardiovascular Monitoring, Temperature Sensing), End User and Region - Global Forecast to 2029
[290 Pages Report] The Electronic Skin Patch market was valued at USD 15.0 billion in 2024 and is estimated to reach USD 27.0 billion by 2029, registering a CAGR of 12.5% during the forecast period. The growth of market is driven by the Surging demand for remote health monitoring solutions, Rapid advancements in flexible electronics, sensors and wireless technologies, growing awareness about early disease detection, and rising geriatric population.
Electronic Skin Patch Market Forecast to 2029
To know about the assumptions considered for the study, Request for Free Sample Report
Market Dynamics:
Driver: Surging demand for remote health monitoring solutions.
The healthcare industry is adopting a new approach to monitoring through remote patient monitoring (RPM). This method involves monitoring patients’ health outside of traditional clinical settings, offering benefits for patients and healthcare providers. Electronic skin patches are emerging as a game-changer in this area due to their comfortable and advanced sensing capabilities. They play a critical role in managing chronic diseases, post-operative care, and eldercare, allowing healthcare providers to remotely monitor patients’ health status and intervene proactively, if necessary. Electronic skin patches are designed with integrated glucose sensors, which can continuously monitor blood sugar levels in real time. This data is valuable for diabetic patients to manage their condition effectively, adjust insulin doses as needed, and prevent complications, such as hypoglycemia or hyperglycemia. Companies, including Dexcom and Abbott Laboratories, have developed continuous glucose monitoring (CGM) systems that utilize electronic skin patches, contributing to the expansion of the electronic skin patch market.
Restraint: Data privacy and security issues
The electronic skin patch market holds immense potential for revolutionizing healthcare. However, concerns about data security and privacy pose a significant hurdle to widespread adoption. These patches collect sensitive health data, making robust security measures crucial for user trust and market growth. Electric skin patches collect a range of personal health data, including heart rate, blood sugar levels, and even brain activity. This data can reveal intimate details about a person’s health. Therefore, it is paramount to secure its storage and transmission to prevent cybercriminals from exploiting vulnerabilities.
Opportunity: Rising emphasis on improving accuracy of health monitoring patches
The electronic skin patch market is expanding with the emergence of new and innovative skin patches aimed at a range of health conditions and functionalities. These patches offer solutions to a broader spectrum of health concerns, appealing to a larger audience. By diversifying their applications, electronic skin patches cater to various demographic groups and medical needs, increasing the potential customer base and driving the market. Advancements in skin patch technology have led to enhancements in their functionality and user experience. These patches boast increased accuracy and reliability in data collection, continuous monitoring capabilities, and non-invasive, painless application methods. In October 2023, BioIntelliSense unveiled the BioSticker+, a health monitoring patch with improved accuracy for temperature, heart rate, and respiration monitoring. This patch boasts a comfortable design and extended wear time up to 7 days..
Challenge: Data overload and limited processing power
Electronic skin patches are designed to collect real-time data on various parameters, such as heart rate, blood pressure, temperature, and humidity. These patches continuously monitor physiological and environmental factors, generating streams of data that require rapid analysis and interpretation. However, e-skins typically rely on off-patch processing units for data analysis, which presents various limitations. For instance, continuous wireless data transmission significantly increases power consumption, leading to a shorter battery life. Additionally, it introduces latency, which hinders real-time applications, such as critical health parameter monitoring. Transmitting sensitive bio-signals also raises security concerns regarding data interception. Managing such vast quantities of data in real time poses a considerable computational burden, especially considering the limited processing power available within the small form factor of an electronic skin patch.
Electronic skin Patch Ecosystem
The market for Monitoring & Diagnostics segment to hold largest market share during the forecast period.
Monitoring & Diagnostics accounts for major share in the electronic skin patch market in the forecast period. With conditions, such as stroke and heart failure, projected to skyrocket, innovative monitoring technologies become paramount. These systems offer real-time insights, enabling timely interventions and improved patient outcomes. The American College of Cardiology predicts significant increases in cardiovascular risk factors and diseases in the US by 2060. Stroke and heart failure are expected to see the highest percentage increases, 33.8% to 15 million and 33.4% to 13 million, respectively, from 2025 to 2060. As the prevalence of heart-related conditions continues to climb, there will be a heightened demand for continuous monitoring and innovative interventions to safeguard patient well-being and mitigate the escalating burden on healthcare systems, driving the demand for electronic skin patches.
Connected segment to grow at the highest CAGR in the Wireless connectivity in the electronic skin patch market during the forecast period.
The prevalence of cardiovascular diseases (CVDs) and diabetes has been steadily rising, contributing to a growing need for continuous monitoring solutions, accelerating the market for connected electronic skin patches. The 2023 World Heart Federation (WHF) highlights a concerning global trend of cardiovascular disease (CVD), revealing a 60% surge in CVD deaths over the last three decades. According to the American College of Cardiology Foundation, global death counts due to CVD increased from 12.4 million in 1990 to 19.8 million in 2022. As per the International Diabetes Federation (IDF), approximately 537 million adults aged 20–79 will be living with diabetes in 2021, with this number expected to rise to 643 million by 2030. This increasing burden underscores the importance of effective monitoring to manage and mitigate the risks associated with these diseases.
Diabetes Management segment in application to the highest market share of the electronic skin patch market during the forecast period
Increasingly sedentary lifestyle, obesity, and an aging population are some of the factors that escalates the demand for innovative solutions in diabetes management. Electronic skin patches offer a promising avenue for addressing the unique needs of diabetic patients. With advantages, such as targeted drug delivery, convenience, and reduced side effects, these patches are poised to revolutionize diabetic care. Increasing diabetes awareness, rising healthcare expenditure, and a strong emphasis on patient-centric care further fuel this growth trajectory.
Healthcare segment in application to the highest market share of the electronic skin patch market during the forecast period
The increasing prevalence of chronic diseases has put significant pressure on hospitals and clinics to find innovative solutions to manage patient care more efficiently. According to the World Health Organization (WHO), chronic diseases are responsible for a large proportion of global deaths, with cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes being the leading causes. These diseases account for approximately 73% of all deaths worldwide, with cardiovascular diseases alone responsible for around 18.6 million deaths annually by 2023. The adoption of electronic skin patches for general patient monitoring is increasing due to a growing focus on preventative healthcare and improved patient outcomes. This trend is driven by the wider adoption of remote patient monitoring technologies and the convenience offered by electronic skin patches.
The Electronic skin patch market in North America is estimated to account for largest share during the forecast period.
North America includes the US, Canada, and Mexico. The market is driven with the increase in consolidation of healthcare providers, widespread adoption of clinical device connectivity & interoperability solutions to curtail the rising healthcare costs, and the rise in the number of heat and diabetic patients in the US. Stringent regulations and guidelines, including the Health Insurance Portability and Accountability Act (HIPPA) and Digital Imaging and Communications in Medicine (DICOM), laid down by government and non-government authorities, such as the Federal Communications Commission (FCC) and the Centers for Medicare and Medicaid Services (CMS) contribute to the dominance of this region.
Electronic Skin Patch Market by Region
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players
Major vendors in the Electronic Skin Patch Companies include Abbott (US), Dexcom, Inc. (US), Medtronic (Ireland), Insulet Corporation (US), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), Biolinq Incorporated (US), Zio By iRhythm Technologies, Inc. (US), GENTAG, Inc. (US), VitalConnect (US), The Surgical Company (Netherlands), Senseonics Ltd. (US), Active Environmental Solutions (Australia), among others. Apart from this, ScottCare (US), VivaLNK, Inc. (US), Bittium (Finland), Cardiomo (US), Seers Technology (South Korea), SIGKNOW (Taiwan), Cortrium (Denmark), Qardio, Inc. (US), LifeSignals (US), Blue Spark Technologies, Inc. (US), Epicore Biosystems (US), HIVOX BIOTEK INC. (US), IontoPatch (US), are among a few emerging companies in the Electronic Skin Patch market.
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Estimated Value |
USD 15.0 billion |
|
Expected Value |
USD 27.0 billion |
|
Growth Rate |
CAGR of 12.5% |
|
Market size available for years |
2020-2029 |
|
Base year |
2023 |
|
Forecast period |
2024-2029 |
|
Segments covered |
Type, Wireless Connectivity, Application, End User, and Region |
|
Geographic regions covered |
North America, Europe, Asia Pacific, and RoW |
|
Companies covered |
The major players include Abbott (US), Dexcom, Inc. (US), Medtronic (Ireland), Insulet Corporation (US), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), Biolinq Incorporated (US), Zio By iRhythm Technologies, Inc. (US), GENTAG, Inc. (US), VitalConnect (US), The Surgical Company (Netherlands), Senseonics Ltd. (US), Active Environmental Solutions (Australia) and Others- total 26 players have been covered. |
Electronic Skin Patch Market Highlights
This research report categorizes the Electronic Skin Patch market into Type, Wireless Connectivity, Application, End User, and Region.
|
Segment |
Subsegment |
|
By Type: |
|
|
By Wireless Connectivity: |
|
|
By Application: |
|
|
By End User: |
|
|
By Region: |
|
Recent Developments
- In March 2024, Dexcom, Inc. introduced its latest continuous glucose monitoring (CGM) system, Dexcom ONE+, in Ireland. Leveraging its top-tier sensor design and incorporating user and healthcare professional feedback, Dexcom ONE+ offers an easy-to-use and highly effective CGM experience for individuals managing Type 1 or Type 2 diabetes with insulin. Studies also indicate cost savings for health services treating individuals with Type 1 diabetes.
- In August 2023, Insulet Corporation announced the full market release of its Omnipod 5 Automated Insulin Delivery System in Germany, expanding its availability beyond the US. The UK Omnipod 5, the first CE-marked tubeless automated insulin delivery system, integrates with the Dexcom G6 Continuous Glucose Monitoring System. SmartAdjust technology and a SmartBolus Calculator offer automated insulin delivery to manage glucose levels, enhancing diabetes management for individuals aged two years and older with type 1 diabetes.
Key Questions Addressed in the Report:
What is the total CAGR expected to be recorded for the electronic skin patch market during 2024-2029?
The global electronic skin patch market is expected to record a CAGR of 12.5% from 2024-2029.
Which regions are expected to pose significant demand for the electronic skin patch market from 2024-2029?
North America & Europe are expected to pose significant demand from 2024 to 2029. Major economies such as US, Germany, China, Japan are expected to have a high potential for the future growth of the market.
What are the major market opportunities for the electronic skin patch market?
Rising emphasis on improving accuracy of health monitoring patches, increasing application beyond traditional healthcare, and Growing awareness about early disease detection are the significant market opportunities in the electronic skin patch market during the forecast period.
Which are the significant players operating in the electronic skin patch market?
Key players operating in the electronic skin patch market are Abbott (US), Dexcom, Inc. (US), Medtronic (Ireland), Insulet Corporation (US), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), Biolinq Incorporated (US), Zio By iRhythm Technologies, Inc. (US), GENTAG, Inc. (US), VitalConnect (US), The Surgical Company (Netherlands), Senseonics Ltd. (US), Active Environmental Solutions (Australia)
What are the major applications of the electronic skin patch market?
Diabetes Management, Cardiovascular Monitoring, General Patient Monitoring are the major application of electronic skin patch market.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
The research process for this study included the systematic gathering, recording, and analysis of data about customers and companies operating in the electronic skin patch market. This research study involved the extensive use of secondary sources, directories, and databases (Factiva, Oanda, and OneSource) to identify and collect valuable information for this extensive, technical, market-oriented, and commercial market study. In-depth interviews were conducted with various primary respondents, including experts from core and related industries and preferred manufacturers, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. Key players in the market were identified through secondary research, and their market rankings were determined through primary and secondary research. This research included studying annual reports of top players and interviewing key industry experts, such as CEOs, directors, and marketing executives.
Secondary Research
Various secondary sources were referred to in the secondary research process to identify and collect information relevant to this study. Secondary sources include annual reports, press releases, and investor presentations of companies; white papers, certified publications, and articles from recognized authors; directories; and databases. Secondary research was mainly done to obtain critical information about the industry’s supply chain, value chain, the pool of key players, and market classification and segmentation according to industry trends, geographic markets, and key developments from market- and technology-oriented perspectives.
Secondary sources included corporate filings (such as annual reports, investor presentations, and financial statements); trade, business, and professional associations; white papers; journals and certified publications; articles by recognized authors; gold-standard and silver-standard websites; directories; and databases. Data was also collected from secondary sources, such as the International Diabetes Federation (IDF), the International Trade Centre (ITC) (Switzerland), and the National Institute of Health (NIH).
Primary Research
Extensive primary research was conducted after understanding and analyzing the current scenario of the electronic skin patch market through secondary research. Several primary interviews were conducted with key opinion leaders from the demand and supply sides across four major regions: North America, Europe, Asia Pacific, and RoW. Approximately 25% of the primary interviews were conducted with the demand side, while 75% were conducted with the supply side. This primary data was collected mainly through telephonic interviews, which accounted for 80% of the total primary interviews. Questionnaires and e-mails were also used to collect data. In canvassing primaries, the report covers various departments within organizations, such as sales, operations, and administration, to provide a holistic viewpoint.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
In the complete market engineering process, top-down and bottom-up approaches and several data triangulation methods have been used to estimate and forecast the size of the market and its segments and sub-segments listed in the report. Extensive qualitative and quantitative analyses have been carried out on the complete market engineering process to list the key information/insights pertaining to the electronic skin patch market.
Key players in the market have been identified through secondary research, and their rankings in the respective regions have been determined through primary and secondary research. This entire procedure involved the study of the annual and financial reports of top players and interviews with industry experts, such as chief executive officers, vice presidents, directors, and marketing executives, for quantitative and qualitative key insights. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources. All parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data has been consolidated and enhanced with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Electronic Skin Patch Market: Bottom-Up Approach
The bottom-up approach has been employed to arrive at the overall size of the Electronic Skin Patch market from the revenues of key players and their share in the market.
Electronic Skin Patch Market: Top-Down Approach
In the top-down approach, the overall size of the electronic skin patch market was used to estimate the size of the individual markets (mentioned in the market segmentation) through percentage splits obtained from secondary and primary research. For calculating the size of specific market segments, the size of the most appropriate parent market was used to implement the top-down approach. The bottom-up approach was also implemented for the data extracted from the secondary research to validate the size of various segments and sub-segments of the market.
The market share of each company was estimated to verify the revenue share used earlier in the bottom-up approach. The data triangulation procedure and data validation through primaries determined and confirmed the individual market size in this study. The data triangulation procedure used for this study was explained in the next section.
Data Triangulation
After arriving at the overall size of the market from the estimation process explained above, the market was split into several segments and sub-segments. The data triangulation and market breakdown procedures were employed (wherever applicable) to complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments. The data was triangulated by studying various factors and trends from the demand and supply sides. The size of the electronic skin patch market was validated using both top-down and bottom-up approaches.
Market Definition
An electronic skin patch is a thin, flexible device embedded with electronic components and sensors that adhere to the skin. It is designed to monitor physiological parameters, such as heart rate, glucose level, temperature, and motion. It also delivers therapeutic agents, including drugs or electrical stimulation, to the body. These patches often incorporate wireless communication capabilities, enabling real-time transmission of data to smartphones or other devices for monitoring or analysis. They offer non-invasive and continuous monitoring, making them valuable in healthcare, fitness, and research applications.
Key Stakeholders
- Raw material and manufacturing equipment suppliers
- Government bodies, venture capitalists, and private equity firms
- Regulatory bodies
- Integrated device manufacturers (IDMs)
- Electronic skin patch component-related intellectual property owners
- Electronic skin patch technology platform developers
- Electronic skin patch component manufacturers
- Distributors and retailers
- Research organizations
- Healthcare providers
- Industry associations and forums
- End users
Report Objectives
- To describe and forecast the electronic skin patch market size, by type, by application, by wireless connectivity and end user, in terms of value
- To describe and forecast the market size, by type, in terms of volume
- To forecast the market size across four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW), in terms of value
- To present detailed information regarding the major factors influencing the market (drivers, restraints, opportunities, and challenges)
- To provide an ecosystem analysis, case study analysis, patent analysis, technology analysis, average selling price analysis, Porter’s Five Forces analysis, and regulations pertaining to the market
- To offer a comprehensive overview of the value chain of the electronic skin patch ecosystem
- To critically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
- To strategically profile key players and comprehensively analyze their market shares and core competencies
- To assess the opportunities for stakeholders and describe the competitive landscape of the market
- To analyze competitive developments, such as collaborations, agreements, partnerships, and product developments, in the market
- To evaluate the impact of the recession on the electronic skin patch market
Available Customizations
With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 7)
Growth opportunities and latent adjacency in Electronic Skin Patch Market